| Thu, Nov 12, 2009 | | | Results From Chelsea Therapeutics' Phase III Trial of Droxidopa in Neurogenic Orthostatic Hypotension to be Presented at 20th Annual International Symposium on the Autonomic Nervous System GlobeNewswire (Thu, Nov 12)
| | Wed, Nov 11, 2009 | | | Chelsea Therapeutics: There Are Safer Rebound Plays at Seeking Alpha (Wed, Nov 11)
| | Fri, Nov 6, 2009 | | | CHELSEA THERAPEUTICS INTERNATIONAL, LTD. Financials EDGAR Online Financials (Fri, Nov 6)
| | | Biotech Stock Mailbag: Poniard Predictions at TheStreet.com (Fri, Nov 6)
| | Tue, Nov 3, 2009 | | | YRC Worldwide: Midday Volume Movers at TheStreet.com (Tue, Nov 3)
| | | Chelsea Just Got Riskier: BioBuzz at TheStreet.com (Tue, Nov 3)
| | | The Long Trade in Chelsea Becomes Riskier: BioBuzz at TheStreet.com (Tue, Nov 3)
| | Mon, Nov 2, 2009 | | | Chelsea Therapeutics International Ltd. Q3 2009 Earnings Call Transcript at Seeking Alpha (Mon, Nov 2)
| | | CHELSEA THERAPEUTICS INTERNATIONAL, LTD. Files SEC form 10-Q, Quarterly Report EDGAR Online (Mon, Nov 2)
| | | Chelsea Therapeutics Reports Third Quarter 2009 Results GlobeNewswire (Mon, Nov 2)
| | | [$$] 13D Filings at Barrons.com (Mon, Nov 2)
| | | Chelsea Therapeutics Appoints Dr. William D. Schwieterman Chief Medical Officer GlobeNewswire (Mon, Nov 2)
| | | Biotech Calendar: Key Dates for November at TheStreet.com (Mon, Nov 2)
| | | Q3 2009 CHELSEA THERAPEUTICS Earnings Release - After Market Close CCBN (Mon, Nov 2)
| | Wed, Oct 28, 2009 | | | Chelsea Therapeutics to Host Conference Call to Discuss Third Quarter 2009 Results GlobeNewswire (Wed, Oct 28)
| | Tue, Oct 27, 2009 | | | Chelsea Therapeutics to Present at the Oppenheimer 20th Annual Healthcare Conference on Wednesday, November 4, 2009 GlobeNewswire (Tue, Oct 27)
| | Fri, Oct 23, 2009 | | | Biotech Calendar: Key Upcoming Trials at TheStreet.com (Fri, Oct 23)
| | Tue, Oct 20, 2009 | | | Neurogenic Orthostatic Hypotension Treatment Should Pass Phase III Trials: Catalyst For Biotech Stock Says Wedbush Morgan Analyst Wall Street Transcript (Tue, Oct 20)
| | | Chelsea Therapeutics Presents Novel, Metabolically Inert Autoimmune Portfolio at the 2009 ACR Annual Scientific Meeting GlobeNewswire (Tue, Oct 20)
| | Fri, Oct 16, 2009 | | | Biotech Stock Mailbag: Oncothyreon at TheStreet.com (Fri, Oct 16)
| Add CHTP News to My Yahoo!:

| |
|